menu

Quintiles Library

Show Filters
Fact Sheet
您想要一个本土合作伙伴还是一个能获得大量全球资源的合作伙伴? 您想要全才还是专家?您是希望双方保持顺畅的深入交流还是提供高科技的服务?自2011年以来,我们为超过45个亚太新兴生物制药客户执行了60个以上的临床研究,无论是国内还是国外新药临床试验,我们了解您将面对的特殊挑战。昆泰向您提供专为亚太区新兴生物制药公司量身定制的专属解决方案,通过临床研究启动、数据管理、使用全球资源进行本地项目管理、患者招募、远程及现场监测/试验执行、全球法规指导及提交、FDA,EMEA/EMA注册等全方位服务,从试验设计到实验室直至进入市场和商业化,助您实现目标。今天就联系我们,询问最困扰您的问题。我们时刻为您准备着。
Read More
Fact Sheet
Quintiles’ HTA Watch is a web-based service offering instant access to a global repository of published HTA reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to help inform life sciences and healthcare companies’ strategic decision-making*. In this edition of our HTA uncovered series, we will look specifically at the latest Royal...
Read More
Fact Sheet
The prevalence of diabetes is expected to increase 55% in the next 20 years, rising from 382 million people living with diabetes in 2013 to 592 million by 2035. You need one global partner to support your research from discovery to post-market. Learn how we helped develop or commercialize the top 30 diabetes drugs of 2013.
Read More
Fact Sheet
As they increasingly outsource to manage complexity and costs, medical device developers can trust Quintiles to help them seize opportunity in Asia Pacific.
Read More
Fact Sheet
The Quintiles Market Intelligence and Market Planning Solution helps you go beyond market research to integrate insights across competitors, products, markets and customers for a fully integrated market intelligence view. We provide strategic direction to your most complex business challenges by bringing together our global team of clinical, commercial and methodological...
Read More
Presentation
Jie Wang, PhD, discusses "Sample Size Estimation For Drug Combination In Fixed Dose Trials" at the 2011 Joint Statistical Meetings, July - August 2011 in Miami.
Explore more
Presentation
Below is a listing of webinars for our biopharma customers that have been created collaboratively by QuintilesIMS Global Marketing and business unit leadership and subject matter experts. Previous Webinars 2016 Webinars The State of Risk-based Monitoring (RBM) Tuesday, June 21, 2016  Speakers: Martin Giblin and Alan Frederickson Watch Understanding...
Explore More
Presentation
Missing data is common in most clinical trials because some subjects withdraw from the trial before the crucial final measurements. Without those final measurements, our picture of the new treatment is imperfect, and it could actually be wrong. What if most of the withdrawals from the new treatment arm dropped out because they felt they were getting worse, or because of...
Watch Webinar
Presentation
Recruitment Metrics From Together RA: A Study in Rheumatoid Arthritis Patients to Evaluate Feasibility of a Direct-to-Patient Research Approach Poster Presentation at Drug Information Association Annual Meeting 2014 By: Elisa Cascade, MBA1, John Reites1, Tia Carmon1, Dawn Blessing2, Joyce Tung2, David Hinds, Ph.D.2 , Chao Tian, Ph.D.2, Diego Miralles, MD ³, Dimitri...
Explore more
Service
Read More
Service
Read More
Service
Determine the best approach Biosimilars pose very different challenges than those presented by small molecule generics: higher costs and more demanding head to head similarity assessments: analytically, non-clinically and clinically: differences in regulatory framework in different markets can deter global investment; and a need for significant investments in sales and...
Read More
Service
Read More
Service
Read More
Service
Read More
Service
Read More
Service
Read More
Service
Read More
Service
Read More
Service
Read More